Prolactin levels in risperidone treatment of first episode schizophrenia.

ČEŠKOVÁ, Eva, Radovan PŘIKRYL, Tomáš KAŠPÁREK and Marta ONDRUŠOVÁ. Prolactin levels in risperidone treatment of first episode schizophrenia. International Journal of Psychiatry in Clinical Practice. 2003, vol. 2003, No 8, p. 1-6. ISSN 1365-1501.

Basic information

Original name

Prolactin levels in risperidone treatment of first episode schizophrenia.

Name (in English)

Prolactin levels in risperidone treatment of first episode schizophrenia.

Authors

ČEŠKOVÁ, Eva (203 Czech Republic, guarantor), Radovan PŘIKRYL (203 Czech Republic), Tomáš KAŠPÁREK (203 Czech Republic) and Marta ONDRUŠOVÁ (203 Czech Republic)

Edition

International Journal of Psychiatry in Clinical Practice, 2003, 1365-1501

---

Other information

Language

Czech

Type of outcome

Článek v odborném periodiku

Field of Study

30000 3. Medical and Health Sciences

Country of publisher

Czech Republic

Confidentiality degree

není předmětem státního či obchodního tajemství

Impact factor

Impact factor: 0.191

RIV identification code

RIV/00216224:14110/03:00021237

Organization unit

Faculty of Medicine

UT WoS

000220242100006

Keywords in English

prolactin; risperidone; schizophrenia

Tags

prolactin, risperidone, schizophrenia

---

Abstract

V originále

Patients with a first-episode of schizophrenia were clinical evaluated by PANSS and prolactinemia was assesed. Patients were treated with risperidon. Risperidon in average dose lower than 4 mg significantly improved both positive and negative symptoms. At the end of acute treatment the average elevation of PRL levels almost doubled the baseline value.There was a trend among responders to return to their initial values during long-term therapy.

In English

Patients with a first-episode of schizophrenia were clinical evaluated by PANSS and prolactinemia was assesed. Patients were treated with risperidon. Risperidon in average dose lower than 4 mg significantly improved both positive and negative symptoms. At the end of acute treatment the average elevation of PRL levels almost doubled the baseline value.There was a trend among responders to return to their initial values during long-term therapy.